UnitedHealth Group has announced the appointment of Wayne S. DeVeydt as Chief Financial Officer, effective September 2, 2025. DeVeydt, who is currently a Managing Director at Bain Capital, has extensive experience in the healthcare sector, having previously served as CFO at Elevance Health and CEO of Surgery Partners. John F. Rex, the current CFO, will transition to a Strategic Advisor role on the same date, having been with the company since 2012.
DeVeydt's employment agreement includes an annual base salary of $1,000,000, participation in incentive compensation plans with a target bonus of 200% of his salary, and a significant stock award target valued at $10,000,000. He will also receive a sign-on bonus of $1,200,000 and a stock award valued at $5,000,000. The terms of his compensation package include various vesting schedules and conditions, as well as eligibility for severance benefits. The leadership change is positioned as a strategic move to enhance UnitedHealth Group's operational capabilities in the healthcare sector.
linkJul 31, 2025 17:08:18
UnitedHealth Group announced its second quarter 2025 results, reporting revenues of $111.6 billion, a year-over-year increase of $12.8 billion. Earnings per share for the quarter were $3.74, with adjusted earnings at $4.08. The company's medical care ratio increased to 89.4%, largely due to rising medical costs that exceeded pricing trends. UnitedHealth has updated its full-year 2025 revenue outlook to between $445.5 billion and $448.0 billion, with earnings per share projected at a minimum of $14.65 and adjusted earnings of at least $16.00 per share. The company also announced a 5% increase in its quarterly dividend to $2.21, returning $4.5 billion to shareholders via dividends and share repurchases in Q2 2025.
In its business segments, UnitedHealthcare reported second quarter revenues of $86.1 billion, driven by growth in Medicare and Medicaid services. However, earnings from operations declined to $2.1 billion from $4.0 billion year-over-year, reflecting higher medical costs and the impact of Medicare funding reductions. Optum, another division, showed mixed results, with Optum Health's revenues decreasing while Optum Insight's revenues grew. Overall, the company is focused on addressing challenges across its lines of business and aims to return to earnings growth in 2026.
linkJul 29, 2025 06:04:05
UnitedHealth Group has initiated contact with the Department of Justice in response to investigations concerning its involvement in the Medicare program. The company is complying with formal requests from the Department and emphasizes its confidence in its practices, citing independent audits that affirm the accuracy of its operations. A prior civil challenge by the Department regarding its Medicare Advantage business concluded without evidence of wrongdoing, according to a court-appointed Special Master.
To enhance transparency, UnitedHealth Group has launched an initiative for third-party reviews of its policies and practices related to risk assessment coding, managed care, and pharmacy services. The company is focused on maintaining the integrity of its business practices and ensuring responsible stewardship of taxpayer funds.
linkJul 24, 2025 08:30:24
UnitedHealth Group has appointed Stephen J. Hemsley as its new CEO, effective immediately, following Andrew Witty’s resignation for personal reasons. Hemsley, who previously served as CEO from 2006 to 2017, will also continue as chairman of the Board of Directors. Witty will transition to a senior advisory role. The company acknowledged Witty's contributions during challenging times and expressed confidence in Hemsley’s leadership capabilities to drive growth moving forward.
In addition to the leadership change, UnitedHealth Group has suspended its outlook for 2025 due to higher-than-expected medical expenditures, particularly among new Medicare Advantage beneficiaries. The company noted an acceleration in care activity and expansion of benefit offerings. However, it anticipates a return to growth in 2026.
linkMay 14, 2025 06:01:00
UnitedHealth Group has reported its first quarter earnings for 2025, revealing earnings of $6.85 per share and adjusted earnings of $7.20 per share, alongside revenues of $109.6 billion, which increased by $9.8 billion year-over-year. The company also revised its full-year guidance, now expecting net earnings between $24.65 and $25.15 per share and adjusted earnings between $26.00 and $26.50 per share. This revision is attributed to higher-than-expected care activity in its Medicare Advantage business and unexpected changes in the member profile affecting reimbursement plans for Optum Health.
The report highlights that UnitedHealthcare served 780,000 more consumers year-to-date, with significant growth in its Medicare Advantage and Optum Health segments. The medical care ratio increased slightly to 84.8%, reflecting ongoing Medicare funding reductions and higher senior care activity. The company returned nearly $5 billion to shareholders through dividends and share repurchases during the quarter, and cash flows from operations were reported at $5.5 billion.
linkApr 17, 2025 06:01:37
UnitedHealth Group announced a revenue increase of $28.7 billion, reaching $400.3 billion in 2024, marking an 8% growth year-over-year. The company also reported that domestic consumers served by UnitedHealthcare rose by 2.1 million, and Optum saw a growth of 600,000 patients served under value-based care. Cash flows from operations amounted to $24.2 billion, demonstrating a solid operational performance, while the return on equity was reported at 23.7% in the fourth quarter. The operating cost ratio improved to 13.2%, reflecting enhanced efficiencies across the business.
On the downside, the medical care ratio increased to 85.5% from 83.2% in 2023, attributed to Medicare funding reductions and other factors. Optum Insight experienced a 1% decline in revenues due to disruptions from a cyberattack, which had a significant financial impact. The company also noted that the number of people served under state-based community offerings decreased to 7.4 million, as expected, due to the conclusion of the Medicaid eligibility redeterminations process. Overall, while the company reported growth in several areas, challenges in medical costs and cyberattack impacts highlighted ongoing operational pressures.
linkJan 16, 2025 06:02:08
UnitedHealth Group expressed deep sadness over the passing of Brian Thompson, the CEO of UnitedHealthcare, highlighting his respect and friendship among colleagues. The company is cooperating with the New York Police Department during this challenging time and extends condolences to Thompson's family and friends.
UnitedHealth Group operates with a mission to improve health and enhance the healthcare system through its two main businesses, Optum and UnitedHealthcare. Optum focuses on delivering care through technology and data, while UnitedHealthcare provides a variety of health benefits aimed at affordability and access to quality care.
linkDec 04, 2024 11:41:32
UnitedHealth Group has provided a financial outlook for 2025, projecting revenues between $450 billion and $455 billion, with net earnings per share expected to be between $28.15 and $28.65. Additionally, the company anticipates adjusted net earnings per share ranging from $29.50 to $30.00, alongside cash flows from operations estimated at $32 billion to $33 billion. This guidance follows the company's previous announcement of 2024 earnings expectations of $15.50 to $15.75 per share.
On the downside, the company has faced challenges related to its South American operations, including losses from the sale of its Brazilian business and ongoing impacts from its remaining South American assets. Furthermore, UnitedHealth Group has incurred costs related to a cyberattack, which may affect its financial performance. The company emphasizes that these challenges are not reflective of its core business performance and aims to provide a clearer picture through adjusted earnings metrics.
linkDec 03, 2024 16:22:33
UnitedHealth Group is set to host its annual Investor Conference on December 4, 2024, in New York City, where company leaders will outline their long-term strategic growth priorities and initiatives aimed at enhancing the consumer experience and expanding value-based care. The event will be accessible via streaming, and materials will be available on the company's Investor Relations website, allowing for broader engagement from analysts and institutional investors.
The press release does not contain specific financial metrics or performance results, nor does it provide detailed insights into any challenges the company may face. Instead, it emphasizes the company's commitment to improving health care quality and accessibility through its two main business segments, Optum and UnitedHealthcare, without addressing any potential risks or negative aspects of its operations.
linkNov 26, 2024 06:56:33
UnitedHealth Group reported impressive third-quarter results for 2024, with revenues reaching $100.8 billion, marking an increase of $8.5 billion from the previous year. The company successfully expanded its consumer base, adding 2.4 million individuals to its commercial offerings year-to-date. Despite facing challenges from a cyberattack that impacted earnings, the adjusted earnings per share showed resilience at $7.15. The company also demonstrated strong operational efficiency, with a notable increase in cash flows from operations and a return on equity of 26.3%.
However, the medical care ratio rose to 85.2%, up from 82.3% the previous year, indicating higher medical costs which may raise concerns among investors. Operating earnings were slightly affected by the cyberattack and business disruption, leading to a decrease in earnings from operations compared to the previous quarter. Additionally, while the company continues to grow its domestic market share, the increased operating costs and the impact of the cyber incident may pose challenges moving forward.
linkOct 15, 2024 06:03:51